A new look at renal dysfunction in the cirrhotic patient

Critical Care

Volumn 16, Issue 1, 2012, Pages

  Francoz, Claire ^a   Durand, François ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TERLIPRESSIN;

ALBUMIN DIALYSIS; DISEASE CLASSIFICATION; END STAGE LIVER DISEASE; HEPATORENAL SYNDROME; HUMAN; KIDNEY DYSFUNCTION; KIDNEY TRANSPLANTATION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NOTE; PRIORITY JOURNAL; PROGNOSIS; UREMIA; VASOCONSTRICTION; VASODILATATION; CONSENSUS DEVELOPMENT; PRACTICE GUIDELINE; RENAL REPLACEMENT THERAPY; STANDARDS;

CONSENSUS DEVELOPMENT CONFERENCES AS TOPIC; HEPATORENAL SYNDROME; HUMANS; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS;

EID: 84857800932     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11207     Document Type: Note

References (15)

1. Nadim MK, Kellum JA, Davenport A, Wong F, Davis C, Pannu N, Tolwani A, Bellomo R, Genyk Y. Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative Group. Crit Care 2012, 16:R23. 10.1186/cc11188, 22322077.
2. Gines P, Schrier RW. Renal failure in cirrhosis. N Engl J Med 2009, 361:1279-1290. 10.1056/NEJMra0809139, 19776409.
3. Gines P, Guevara M, Arroyo V, Rodes J. Hepatorenal syndrome. Lancet 2003, 362:1819-1827. 10.1016/S0140-6736(03)14903-3, 14654322.
4. Moreau R, Lebrec D. Acute renal failure in patients with cirrhosis: perspectives in the age of MELD. Hepatology 2003, 37:233-243. 10.1053/jhep.2003.50084, 12540770.
5. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Schölmerich J. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996, 23:164-176. 10.1002/hep.510230122, 8550036.
6. Salerno F, Gerbes A, Gines P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007, 56:1310-1318. 1954971, 17389705.
7. Trawale JM, Paradis V, Rautou PE, Francoz C, Escolano S, Sallee M, Durand F, Valla D, Lebrec D, Moreau R. The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study. Liver Int 2010, 30:725-732. 10.1111/j.1478-3231.2009.02182.x, 20040048.
8. Francoz C, Prie D, Abdelrazek W, Moreau R, Mandot A, Belghiti J, Valla D, Durand F. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010, 16:1169-1177. 10.1002/lt.22128, 20879015.
9. Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 2010, 52:605-613. 10.1016/j.jhep.2009.11.025, 20185192.
10. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11:R31. 10.1186/cc5713, 2206446, 17331245.
11. Moreau R, Durand F, Poynard T, Duhamel C, Cervoni JP, Ichaï P, Abergel A, Halimi C, Pauwels M, Bronowicki JP, Giostra E, Fleurot C, Gurnot D, Nouel O, Renard P, Rivoal M, Blanc P, Coumaros D, Ducloux S, Levy S, Pariente A, Perarnau JM, Roche J, Scribe-Outtas M, Valla D, Bernard B, Samuel D, Butel J, Hadengue A, Platek A, et al. Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002, 122:923-930. 10.1053/gast.2002.32364, 11910344.
12. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, . United Network for Organ Sharing Liver Disease Severity Score Committee Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003, 124:91-96. 10.1053/gast.2003.50016, 12512033, United Network for Organ Sharing Liver Disease Severity Score Committee.
13. Gonwa TA, McBride MA, Anderson K, Mai ML, Wadei H, Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?. Am J Transplant 2006, 6:2651-2659. 10.1111/j.1600-6143.2006.01526.x, 16939515.
14. Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS. Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl 2009, 15:1142-1148. 10.1002/lt.21821, 19718633.
15. Locke JE, Warren DS, Singer AL, Segev DL, Simpkins CE, Maley WR, Montgomery RA, Danovitch G, Cameron AM. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation 2008, 85:935-942. 10.1097/TP.0b013e318168476d, 18408571.